Baricitinib for treating severe alopecia areata

  • Technology appraisal guidance
  • TA926
  • Published: 

Notice of Appeal

Baricitinib for treating severe alopecia areata [ID3979]

This appeal hearing will hear appeals against the Final Draft Guidance for the above technology by the following organisations:

  • Alopecia UK

 The appeal panel will convene on Tuesday 12 September 2023 via Zoom to hear oral representations from the appellants.

This page was last updated: